Jefferies Reiterates Buy Rating on ANI Pharmaceuticals (ANIP) following Keenova report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 72.00 -1.16 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.16 | 52 Week High | $70.92 | |||
| Open | $73.27 | 52 Week Low | $26.80 | |||
| Day High | $73.54 | P/E | N/A | |||
| Day Low | $71.90 | EPS | $-0.96 | |||
| Volume | 286,897 | |||||
